-
My Account
In App
My Account
BSE Live
Oct 28, 09:32Prev. Close
50.71
Open Price
51.99
Bid Price (Qty.)
49.12 (7)
Offer Price (Qty.)
51.68 (68)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Pharmaids Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 2.34 | 0.03 | 0.00 | 3.94 | 8.55 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 2.34 | 0.03 | 0.00 | 3.94 | 8.55 | |
| Total Operating Revenues | 2.34 | 0.03 | 0.00 | 3.94 | 8.55 | |
| Other Income | 1.02 | 0.80 | 0.00 | 0.02 | 0.03 | |
| Total Revenue | 3.36 | 0.82 | 0.00 | 3.95 | 8.58 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchase Of Stock-In Trade | 11.52 | 0.25 | 0.00 | 4.09 | 8.53 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -9.54 | -0.23 | 0.89 | -0.52 | -0.37 | |
| Employee Benefit Expenses | 3.42 | 1.99 | 1.13 | 0.04 | 0.04 | |
| Finance Costs | 2.15 | 0.33 | 0.00 | 0.00 | 0.00 | |
| Depreciation And Amortisation Expenses | 0.20 | 0.18 | 0.02 | 0.01 | 0.04 | |
| Other Expenses | 4.17 | 4.39 | 7.87 | 0.19 | 0.24 | |
| Total Expenses | 11.95 | 6.91 | 9.91 | 3.81 | 8.49 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -8.59 | -6.09 | -9.91 | 0.14 | 0.09 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -8.59 | -6.09 | -9.91 | 0.14 | 0.09 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -1.31 | -1.14 | -2.35 | 0.00 | 0.00 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | -1.31 | -1.14 | -2.35 | 0.00 | 0.00 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -7.28 | -4.95 | -7.56 | 0.15 | 0.09 | |
| Profit/Loss From Continuing Operations | -7.28 | -4.95 | -7.56 | 0.15 | 0.09 | |
| Profit/Loss For The Period | -7.28 | -4.95 | -7.56 | 0.15 | 0.09 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -2.06 | -2.18 | -5.86 | 0.14 | 0.09 | |
| Diluted EPS (Rs.) | -2.06 | -2.18 | -5.86 | 0.14 | 0.09 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
22.08.2025
Pharmaids Pharm Standalone June 2025 Net Sales at Rs 1.12 crore, up 569.85% Y-o-Y
27.05.2025
Pharmaids Pharm Standalone March 2025 Net Sales at Rs 0.13 crore, up 1792.86% Y-o-Y
04.03.2025
Pharmaids Pharm Consolidated December 2024 Net Sales at Rs 4.71 crore, up 22595.42% Y-o-Y
23.05.2022
Pharmaids Pharm Standalone March 2022 Net Sales at Rs 0.30 crore, down 83.95% Y-o-Y
